Q2 FY2026 Earnings
Financial report interval: 2026.03.30 - 2026.06.30
Overview: ADARx Pharmaceuticals(ADRX) the Revenue is 746 K (+258.7%);the EBIT is -29.89 M (-41.52%);the EPS is -2.27 (-42.8%).
Actual
YoY
Estimate
YoY
Vs estimate
YoY
Revenue
0.00B258.65%
----
----
EBIT
-0.03B41.52%
----
----
EPS
-2.274942.80%
----
----
Revenue
ActualEstimateUnit: USD
qf
EBIT
ActualEstimateUnit: USD
qf
Net income
ActualEstimateUnit: USD
qf
EPS
ActualEstimateUnit: USD
qf